Ameritas Investment Partners, Inc. Arcellx, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.84 Billion
- Q2 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,223 shares of ACLX stock, worth $349,495. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,223
Previous 3,970
6.37%
Holding current value
$349,495
Previous $276,000
15.58%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ACLX
# of Institutions
173Shares Held
45.6MCall Options Held
53.6KPut Options Held
53.7K-
Perceptive Advisors LLC New York, NY3.89MShares$322 Million6.21% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.85MShares$318 Million8.59% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$310 Million19.51% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$291 Million0.0% of portfolio
-
Sr One Capital Management, LP2.35MShares$194 Million56.87% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.63B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...